Trial Profile
Phase I/II trial of Agrippal (influenza vaccine) adjuvanted with IC 31.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Jun 2011
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- 06 Mar 2008 New trial record.